Free to read · nothing for sale · no ads, no sponsors · funded by donation

Open Source Apothecary At Home

Open Source Apothecary At Home / Urinary and reproductive

Urinary incontinence and overactive bladder

Pelvic floor training has better evidence than any supplement, and it is free.

remedy

Incontinence is common, treatable, and under-discussed, and the intervention with the best evidence is a supervised pelvic floor muscle training programme — better than medication for stress incontinence, and effective for urgency and mixed incontinence too.

Stress incontinence — leaking on coughing, laughing, lifting, running — responds to pelvic floor muscle training with cure rates comparable to surgery in some trials and with better durability than surgery in the longer follow-up of the better studies. It takes 3-6 months of supervised training.

Overactive bladder and urgency — pelvic floor training, bladder training (delaying voiding by progressively longer intervals), reducing caffeine and alcohol, weight loss, and treating constipation. Anticholinergic drugs are used and have side effects including cognitive ones, particularly in older adults; there is a real case for trying behavioural treatment first.

The supplements sold for this have essentially no evidence. Pumpkin seed, soy isoflavones, and various herbal blends have small or absent trial data.

The things that need ruling out first, and they are the reason this is a clinician's conversation. A urinary infection; diabetes; a medication effect (diuretics, some antihypertensives, sedatives); vaginal atrophy (treatable with topical oestrogen); an enlarged prostate or a fibroid pressing on the bladder; a neurological condition; and, in a woman with leakage, a fistula after pelvic surgery. New incontinence is a symptom, not a diagnosis.

The practical measures. Timed and prompted voiding; treating constipation; weight loss; reducing caffeine and alcohol; adequate fluid intake but not excessive (restricting fluid concentrates the urine, irritates the bladder and makes urgency worse — a common error); and absorbent products as a bridge while the training works.

In men, always exclude prostate obstruction. A man with incontinence and a poor stream needs assessment before any behavioural programme.

What the studies found

Meta-Analysis2025Age and ageing

The importance of electrical parameters on transcutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis.

Electrical parameters may impact effectiveness (in favour of 10 Hz, motor threshold).
PubMed 40711757 ↗
Meta-Analysis2025Journal of thrombosis and haemostasis : JTH

Etiology and diagnosis of heavy menstrual bleeding among adolescent and adult patients: a systematic review and meta-analysis of the literature.

Many diagnoses were associated with bleeding disorders and, therefore, warrant investigation when assessing a patient with HMB of unknown etiology.
PubMed 39617186 ↗
Meta-Analysis2025Archives of gynecology and obstetrics

Efficacy of GnRH antagonists in the treatment of uterine fibroids: a meta-analysis.

GnRH antagonists represent an effective alternative for uterine fibroids treatment as they allow a superior reduction in menstrual bleeding and uterine fibroid volume compared to the placebo group.
PubMed 39821450 ↗
Meta-Analysis2024Brazilian journal of physical therapy

Isolated bladder training or in combination with other therapies to improve overactive bladder symptoms: a systematic review and meta-analysis of randomized controlled trials.

In the short term, BT plus IVES improves the OAB symptoms of nocturia and UI while improving QoL.
PubMed 39106788 ↗

Preparation

Pelvic floor muscle training (the treatment)

  • Identify the muscle: stop the flow of urine mid-stream once, to learn which muscle it is. Do not do this repeatedly — it causes incomplete emptying.
  • Then practise: squeeze and lift, hold 5 seconds, relax 5 seconds, 10 repetitions, three times a day
  • Build to holding 10 seconds with 10 repetitions, three sets a day
  • Supervised training with a physiotherapist specialising in pelvic health is far more effective than unsupervised. Ask for a referral.
  • Give it 3-6 months

Bladder training for urgency

  • Void on a schedule, then extend the interval by 15 minutes a week
  • When urgency comes, do 3-5 quick pelvic floor squeezes and wait for it to pass
  • Keep a bladder diary

The practical measures

  • Treat constipation — a loaded rectum worsens urgency
  • Reduce caffeine and alcohol, both bladder irritants
  • Weight loss where relevant; a real effect on stress incontinence
  • Do not restrict fluid — it concentrates the urine and worsens urgency. Aim for normal intake.
  • Absorbent products as a bridge, not a solution

What needs ruling out

  • Urinary infection, diabetes, medication effects, vaginal atrophy, prostate obstruction, fibroids, neurological causes
  • New incontinence is a clinician's assessment, and the treatable causes are common

Supplements

  • Pumpkin seed, soy isoflavones and herbal blends: no meaningful evidence. Do not spend on them instead of the training.

Cautions and interactions

When this is not a self-care problem — get help

Related

Sources

  1. The importance of electrical parameters on transcutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. Age and ageing 2025; doi:10.1177/1359105314522084 PubMed 40711757
  2. Etiology and diagnosis of heavy menstrual bleeding among adolescent and adult patients: a systematic review and meta-analysis of the literature. Journal of thrombosis and haemostasis : JTH 2025; doi:10.1016/j.jtha.2024.11.014 PubMed 39617186
  3. Efficacy of GnRH antagonists in the treatment of uterine fibroids: a meta-analysis. Archives of gynecology and obstetrics 2025; doi:10.1016/j.fertnstert.2020.02.114 PubMed 39821450
  4. Isolated bladder training or in combination with other therapies to improve overactive bladder symptoms: a systematic review and meta-analysis of randomized controlled trials. Brazilian journal of physical therapy 2024; doi:10.1007/s00192-022-05088-7 PubMed 39106788